Cyber knife is a non-invasive, painless robotic radiosurgery system used in the treatment of brain tumors such as malignant, and non-malignant tumors. It is also considered to be a radiosurgery device that do not require frame for targeting. It is also known as the synchrony system or synchrony method that uses a combination of surgical placed internal fiducials and light emitting optical fibers that is mounted on the patient body where the optical fibers are tracked by infrared tracking camera. Cyber knife radiosurgery benefit to patients who have previously received large doses of radiation therapy. The cyber knife radiosurgery treatment can be completed in 1 to 5 days treatment sessions with each treatment session lasts between 30 to 90 minutes. It can be used alone to treat the brain metastases.
The cyber knife system comprises of diagnostic x-ray tube, 6 MV linear accelerator, secondary collimator, robot gantry, silicon X-ray detectors, and patient couch. Cyber knife systems has a Food and Drug Administration (FDA) clearance for the treatment of tumors such as head, neck cancers, spinal lesions, pancreas, and malignant tumors. Potential benefits of the cyber knife system includes no incision, no loss in blood, no pain, no overnight hospitalization, also it is faster and more accurate and patient can breathe normally during treatment. This treatment is based on the principle of destruction of cancerous cells by distracting their DNA by radiation, helps to slower the growth of cancerous cells.
Cyber knife market taxonomy
Cyber Knife Market by Application:
Cyber Knife Market End-User:
Cyber Knife Market by Geography:
Increase in incidences of cancer around the globe is expected to support the growth in cyber knife system market over the forecast period
Cyber knife is known for its radiology accuracy of 0.5 mm to 1.1 mm, which are used to treat cancerous cells or brain tumors. Geographically, North America and Europe regions are projected to lead the demand for cyber knife market due to the increase in geriatric population, prevalence of chronic diseases and growing demand for less time consuming treatments, increase in incidence of cancer and a shift towards painless and non-invasive surgeries. As owing to the large patient population pool in the countries such as China and India, cyber knife market is projected to grow in the forecast period.
In 2016, according to the American Cancer Society, it was estimated around 1,690,000 cases of cancer were diagnosed and around 596,000 cancer deaths occurred in the U.S. due to the increase in geriatric population, lack of physical exercise, over weight an and smoking accounts for high proportion of cancer worldwide, this is expected to led the demand for the cyber knife system in the near future.
According to the Cancer Research UK, Worldwide cancer cases were around 14.1 million, deaths were around 8.2 million in 2012, whereas worldwide 1 million adults currently smoke cigarettes and smoking is the most preventable cause of death in the world, the second most is alcohol consumption. According to the American Cancer Society, in Europe, it was estimated around 3.5 million new cancer cases occurred in 2012, lung and colorectal cancer are the most common causes of cancer death in this region.
The Major Key Players of Cyber Knife Market Includes:
Accuray Incorporated, BrainLab, Elekta AB, Nucletron B.V., GE Healthcare, Hitachi America, IBA Group, Mitsubishi Electric, Nordion, Philips Healthcare, RaySearch, Sumitomo Heavy Industries, Varian Medical Systems, Modus Medical Devices Inc., Varian Medical Systems International AG, GE Healthcare, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, and Shenzhen GeneMDx Biotech. Co., Ltd.